SBS

Why is Pfizer's rollout of its anti-COVID pill so slow?

Pfizer's antiviral COVID-19 pill for at-risk people aged 12 and above has been authorised in the US.

Source: AAP

SBS Nepali
View Podcast Series
Download the SBS Audio appAvailable on iOS and Android

Pfizer's COVID-19 treatment pill Paxlovid was the first pill authorized in the U-S to treat coronavirus.But since its approval, there have been questions as to why it takes so long to make. While the time frame to make the pill isn't unusual, some are wondering if supplies will improve.

Share

Latest podcast episodes

Nepal New Government
A composite image generated on Monday, September 22, 2025. Signage at an Optus store in Melbourne, Monday, September 22, 2025. (AAP Image/Erik Anderson) NO ARCHIVING
Brisbane
AFL BROWNLOW MEDAL
Follow SBS Nepali
facebook
X (Twitter)
youtube
Download our apps
SBS Audio
iOSAndroid
SBS On Demand
iOSAndroid
Listen to our podcasts
SBS Nepali
Independent news and stories connecting you to life in Australia and Nepali-speaking Australians.
Mum Mane Ama
Stories about women of Nepali heritage in Australia who are about to become parents.
Get the latest with our exclusive in-language podcasts on your favourite podcast apps.
Watch on SBS
Nepali News

Nepali News

Watch it onDemand
Watch nowOn Demand
Why is Pfizer's rollout of its anti-COVID pill so slow? | SBS Nepali